It has been hypothesized that a 2 -adrenoceptors (a 2 -ARs) may be involved in the pathomechanism of colitis; however, the results are conflicting because both aggravation and amelioration of colonic inflammation have been described in response to a 2 -AR agonists.Therefore, we aimed to analyze the role of a 2 -ARs in acute murine colitis. The experiments were carried out in wild-type, a 2A -, a 2B -, and a 2C -AR knockout (KO) C57BL/6 mice. Colitis was induced by dextran sulfate sodium (DSS, 2%); alpha 2 -AR ligands were injected i.p. The severity of colitis was determined both macroscopically and histologically. Colonic myeloperoxidase (MPO) and cytokine levels were measured by enzyme-linked immunosorbent assay and proteome profiler array, respectively. The nonselective a 2 -AR agonist clonidine induced a modest aggravation of DSSinduced colitis. It accelerated the disease development and markedly enhanced the weight loss of animals, but did not influence the colon shortening, tissue MPO levels, or histologic score. Clonidine induced similar changes in a 2B -and a 2C -AR KO mice, whereas it failed to affect the disease activity index scores and caused only minor weight loss in a 2A -AR KO animals. In contrast, selective inhibition of a 2A -ARs by BRL 44408 significantly delayed the development of colitis; reduced the colonic levels of MPO and chemokine (C-C motif) ligand 3, chemokine (C-X-C motif) ligand 2 (CXCL2), CXCL13, and granulocytecolony stimulating factor; and elevated that of tissue inhibitor of metalloproteinases-1. In this work, we report that activation of a 2 -ARs aggravates murine colitis, an effect mediated by the a 2A -AR subtype, and selective inhibition of these receptors reduces the severity of gut inflammation.